脑卒中患者颈动脉粥样硬化性狭窄的危险因素研究
|
摘要
目的：根据卫生部脑卒中筛查项目分析脑卒中及颈动脉粥样硬化性狭窄的危险因素,为我院脑卒中的筛查提供更全面的标准。
方法：1、160例样本来自2010年12月-2012年3月在甘肃省人民医院神经内科住院且符合卫生部规定的脑卒中筛查标准并进行脑卒中筛查的患者,男72例,女88例,年龄≥40岁,平均(60±7.23)岁。
2、收集临床资料并填写“脑卒中高危人群风险初筛评估简表”,再进一步进行体格检查,实验室检查,颈部血管超声检查。
3、危险因素分析采用SPSS19.0统计软件进行分析。
结果：1、男性,年龄>40岁,血脂代谢异常,牙周疾病,高同型半胱氨酸血症和高纤维蛋白原血症是颈动脉粥样硬化性狭窄的危险因素。2、颈动脉粥样硬化性狭窄的程度越重血浆同型半胱氨酸和纤维蛋白原的含量越高。
结论：1、积极预防血脂代谢异常,牙周疾病,高同型半胱氨酸血症和高纤维蛋白原血症可以在一定程度上延缓颈动脉粥样硬化的发生。2、在卫生部规定的脑卒中筛查基本项目中增加血浆同型半胱氨酸及纤维货白原含量的检测可以及时预防Hcy和Fib的升高,为预防颈动脉粥样硬化的形成提供科学依据。
Objective:To analysis the risk factors for carotid atherosclerotic stenosis by the screening for stroke which was put forward by Ministry of Public Health,and provide more overall screen contents for screening of stroke.
Methods:1.160samples who were from neurology patients in our hospital from december2010to march2013.The160samples all fit for Screening standards and have been screened,72male patients,88female patiens, age≥40years old, mean age60±7.23years.
2.Fist,Collecting clinical data and fill in Basic stroke screening information table, medical examination: Second.carry on physical examination, laboratory investigation, cervical vascular ultrasonography for the patients.
3.Factors were analyzed by SPSS16.0.
Outcomes:1.Male, age≥40years old, abnormal lipid metabolism, Periodontal disease, hyperhomocysteinemia and high fibrinogen in blood are all the fctors of Carotid atherosclerotic stenosis.2.The degree of the stricture is more serious the level of Hcy and FIB are more high.
Conclusion:1.Prevent abnormal lipid metabolism,Periodontal disease hyperhomocysteinemia and high fibrinogen in blood can postpone the occurrence of Carotid atherosclerotic stenosis in a way.2.Add the detection of the Hcy and Fib can prevent the increases of Hcy and Fib,to take precautions against Carotid atherosclerotic stenosis.
方法：1、160例样本来自2010年12月-2012年3月在甘肃省人民医院神经内科住院且符合卫生部规定的脑卒中筛查标准并进行脑卒中筛查的患者,男72例,女88例,年龄≥40岁,平均(60±7.23)岁。
2、收集临床资料并填写“脑卒中高危人群风险初筛评估简表”,再进一步进行体格检查,实验室检查,颈部血管超声检查。
3、危险因素分析采用SPSS19.0统计软件进行分析。
结果：1、男性,年龄>40岁,血脂代谢异常,牙周疾病,高同型半胱氨酸血症和高纤维蛋白原血症是颈动脉粥样硬化性狭窄的危险因素。2、颈动脉粥样硬化性狭窄的程度越重血浆同型半胱氨酸和纤维蛋白原的含量越高。
结论：1、积极预防血脂代谢异常,牙周疾病,高同型半胱氨酸血症和高纤维蛋白原血症可以在一定程度上延缓颈动脉粥样硬化的发生。2、在卫生部规定的脑卒中筛查基本项目中增加血浆同型半胱氨酸及纤维货白原含量的检测可以及时预防Hcy和Fib的升高,为预防颈动脉粥样硬化的形成提供科学依据。
Objective:To analysis the risk factors for carotid atherosclerotic stenosis by the screening for stroke which was put forward by Ministry of Public Health,and provide more overall screen contents for screening of stroke.
Methods:1.160samples who were from neurology patients in our hospital from december2010to march2013.The160samples all fit for Screening standards and have been screened,72male patients,88female patiens, age≥40years old, mean age60±7.23years.
2.Fist,Collecting clinical data and fill in Basic stroke screening information table, medical examination: Second.carry on physical examination, laboratory investigation, cervical vascular ultrasonography for the patients.
3.Factors were analyzed by SPSS16.0.
Outcomes:1.Male, age≥40years old, abnormal lipid metabolism, Periodontal disease, hyperhomocysteinemia and high fibrinogen in blood are all the fctors of Carotid atherosclerotic stenosis.2.The degree of the stricture is more serious the level of Hcy and FIB are more high.
Conclusion:1.Prevent abnormal lipid metabolism,Periodontal disease hyperhomocysteinemia and high fibrinogen in blood can postpone the occurrence of Carotid atherosclerotic stenosis in a way.2.Add the detection of the Hcy and Fib can prevent the increases of Hcy and Fib,to take precautions against Carotid atherosclerotic stenosis.
引文
[1]Zhao D, Liu J, Wang W, et al. Epidemiological transition of stroke in China:twenty-one-year observational study from the Sino-MONICA-Beijing Project[J]. Stroke,2008,39(6):1668-1674.
[2]白雁明,胡淑丽,秦艳芬,朱晓波.颈动脉狭窄与复发性脑梗死的关系探讨[J].当代医学,2011,17(19).
[3]王拥军.应加强颈动脉粥样硬化的基础和临床研究[J].中华神经科杂志,2001,34(5)：257-258.
[4]赵红梅,辛涛.高同型半胱氨酸血症与心脑血管病[J].陕西医学杂志,2006,11(35)1491-1492.
[5]马雪兴,刘玉明,吾柏铭.蛋氨酸对兔同型半胱氨酸水平及动脉粥样硬化的影响[J].中国心血管杂志,2002,7(4)：231-234.
[6]WerstuckG.H,LentzS.R,DayalS,et al.Homocysteine-induced endoplasmic reticulum Stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways.Journal of clinical investigation,2001,107(10):1263-1273.
[7]Zhou J,Werstuck G.H,Lhotak S,et al.Association of Multiple Cellular Stress Pathways With Accelerated Atherosclerosis In Hyperhomocysteinemic A polipo protein E-Deficient Mice.Circulation,2004,110(2):207-213.
[8]Kannellis J, Kang DH.Uric acid as a mediator of endothelial dysfunction, inflammation and vascular d isease [J]Sem in Nephro,12005(25):39-42.
[9]王杏儒,赵娜萍,刘瑛.血浆纤维蛋白原浓度对颈动脉粥样硬化程度的影响[J].河北医药,2007，29：712.
[10]Megson E,Fitzsimmons T,Dharmapatni K,et al.C-reactive protein in gingival crevicular fluid may be indicative of systemic inflammation[J].Clin Periodontol,2010,37(9):797-804.
[11]Ylostalo P,Anttila S,Rajala U,et al.Periodontal infection and subclinical atherosclerosis:the role of high-density lipoprotein as a modifying factor[J].Clin Periodontol,2010,37(7):617-624.
[12]D' Aiuto F.Parker M,Nibali L,Suvan J,Lessem J,Tonetti MS,Periodontal infections cause changes in traditional and novel cardiovascular risk factors:results from a randomized controlled clinical trial[J].Am Heart,2006,151(5):977-984.
[13]王瑾,刘海夏,陈红.牙周疾病与颈动脉狭窄程度的关系[J].中国老年学杂志,2012,32.
114] LI GW.zheng GY,LI JG.et al. Relationship between carotid atherosclerosis and cerebral infarction[J].Chin Med Sci,2010.25(1):32-37.
[15]王兰琴,魏秀娥,荣良群.脑梗死患者颈动脉斑块稳定性及其相关因素分析[J].中国实用神经疾病杂志,2012,15(4).
[16]Ross R.Atherosclerosis-Aninflammatory disease[J].N Engl J Med,1999,340:115-126.
[17]赵东娅.颈动脉粥样硬化与脑梗死复发的关系研究[J].中国医药指南,2011,9(22)
[18]姚光辉,余新,朱红梅.颈动脉粥样硬化与血清同型半胱氨酸水平变化的关系[J].中国自然医学杂志.2008,10(6).
[19]赵红梅,辛涛.高同型半胱氨酸血症与心脑血管病[J].陕西医学杂志,2006，35：1492-1492.
[20]Kawamoto.Takaaki Doi and Hitoo Tokunaga.Association of Plasma Homocysteine Concentrations with. ORIGINAL ARTICLE,2011,12 (40)
[21]耿彬,常林,杜军保.防治高同型半胱氨酸血症的新策略[J].北京大学学报(医学版)2005,37(32).
[22]谢秋玲.颈动脉彩超筛查3000例临床分析及脑卒中管理系统的健康干预研究[J].中国社区医师,2011,29(13).
[23]Casella IB,Sotelo FJB,Yamazaki Y,et al.Comparison of common carotid artery intima-media thickness between brazilian eurodescendants and afrodescendants with atherosclerosis risk factors[J].Clinics,2009,64(7):657-64.
[24]Alon Eisen, MD; Michal Benderly, PhD; Uri Goldbourt, PhD; Moti Haim, MD.Association of elevated serum uric acid with coronary heart disease in diabetes mellitus. Clin Cardiol,2013 Feb;36(2):110-6.
[25]Kang DH,Park SK, Lee IK.et al. Uric acid-induced C-reactive protein expression:implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol,2005; 16:3553-3562.
[26]Hayden MR, Tyagi SC. Uric acid:a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus:the urate redox shuttle. Nutrition Metabolism,2004; 1:1-15.
[27]Watanabe S, Kang DH, Feng L, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity[J].Hypertension,2002,40(3):355-360.
[28]Tribouilloy C, Pelt ier M, Colas L, et al. Fibrinogen is an independent marker for thoraci caortic atherosclerosis [J]. Am J Cardiol,1998,81(3):321-326.
[29]Naito M, Hayashi T, Lguchi A. New approaches to the prevention of atherosclerosis[J].Drugs,1995,50 (3):440-453.
[30]解龙吕,黄如训.纤维蛋白原与脑动脉系统血栓形成[J].国外医学脑血管病分册,2002,l()(5)：370-376.
[31]Bini A, Kudryk BJ. Fibrinogen and fibrin in the arterial wall [J].Thromb Res,1994,75(3): 337-341.
[32]O' Connor S, Taylor C, Campbell LA. et al. Potential infectious etiologies of atherosclerosis:A multifactorial perspective[J]. Emerg Infect Dis,2001.7(5):780-788.
[33]D' Aiuto F, Parkar M. Andreou G. et al. Periodontitis and atherogenesis:Causal association or simple coincidence[J]. J Clin Periodontol,2004,31 (5):402-411.
[34]Gibson FC 3rd, Hong C.Chou HH, et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice[J]. Circulation.2004.109 (22) 2801-2806.
[35]Katz.IT, Shannon RP. Bacteria and coronary atheroma:More fingerprints but no smoking gun[J]. Circulation,2006,113 (7):920-922.
[36]Randomised trial of cholesterol lowering in 4444patients with coronary heart disease:the Scandinavian Simvastatin Survival Study(4S)[J].Lancet,1994,344:1383-1389.
[37]Prevention of cardiovascular events and death with pravastatin In patients with coronary heart disease and a broad range of initial cholesterol levels.The Long-Term intervention with Pravastatin in ischaemic Disease(LIPID)Study Group[J].NEngl J Med.1998.339:1349-1357.
[38]PhanB A,Chu B,Pollssar N,I latsukami T S,Yuan C,Zhao X Q. Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging.[J]Int J Cardiovasc Imaging,2007,23:337-342.
[39]朱云松,王玲,李进.血管平滑肌细胞凋亡与动脉粥样硬化[J].国外医学老年医学分册,1997,18(2)：53-57.
[40]Lane P. Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in Thelper (Th) 1 and Th2 cells [J].J Exp Med,2000,191 (2):201-206.
[41]Wang X, Ria M, Kelmenson PM, et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility [J]. Nat Genet,2005,37 (4) 365-372.
[42]中华神经科学会.各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6)：319-21.
[43]吴晓晖,于小红,盛红专.血压变异性与高血压伴颈动脉粥样硬化的关系[J].中国交通医学杂志,2005,19(6).
[44]Matsmoto K,Sera Y,Nakamura H,et al.Correlation between common carotid arterial wall thickness and ischemic stroke in patients with type 2 diabetes mellitus[J].Metabolism,2002,51:2421-7.
[45]赵婷,朱秀英,陈琳.再发脑梗死危险因素分析及预防[J].新疆医科大学学报,2001,24(2)：167-8.
[46]Smimov AV,Potrish chev NN,Panina llu Glomerular filtration rate is an indicator of endothelial function at carly stages of chronic kidney disense[J].Tar Arkh,2007,79:25-30.
[47]杨倩,于德林.年龄与性别对颈动脉粥样硬化影响的超声观察[J].临床超声医学杂志.2012年8月第14卷第8期.
[48]Bode-Boger SM, Scalera F, Martens-Lobenhoffer J, et al. Asymetric dimethylarginine (ADMA) accelerates cell senescence. Vasc Med,2005,10 (Suppl 1):65-71.
[49]Cevik D, Unay O, Durmusoglu F, et al. Plasma markers of No synthase activity in women after ovarian hyperstimulation:influence of estradiol on ADMA. Vasc Med.2006,11 (1):7-12.
[50]SINNING C, WILD PS, ECHEVARRIA F M, et al. Sex differences in early carotid atherosclerosis (from the Community-Based Gutenberg-Heart Study) [J].Am J Cardiol,2011,107(12):1841-1847.
[51]尚娟.激素替代疗法与冠心病预防[J].中华医学实践杂志,2006,7(12)：1429-1432.
[52]袁志敏.早期颈动脉粥样硬化的性别差异[J].心血管病学进展.2012年7月第33卷第4期.
[53]王纯正,徐智章.超声诊断学[M],2版,北京：人民卫生出版社,2010：150.
[54]贺顺龙,朱兆洪,陈宝国,林煜,白建萍,邓国良,梁玉玲.超声检测脑血管病高危人群颈动脉内皮舒张功能[A].中国动脉硬化杂志,2004,12(2).
[55]万杰清,李善泉,江基尧.血管内超声在颈动脉粥硬化研究中的应用——与血管造影和组织病理学的比较研究[J].中国卒中杂志,2008,3(12).
[56]Glagov S, Weisenberg E, Zanns CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries[JJ. N Engl J Med,1987,316:1371-1375.
[57]洪钰锟,迟路湘，宋治运.血管内超声用于颈动脉狭窄诊治的研究[J].重庆医学，2008,37(23).
[58]Clark DJ.Lessio S.O' Donoghue M,et al. Safety and utility of int ravascular ult rasound guided carotid artery stenting[J]. Cathet Cardiovasc Intervent,2004,63:355.
[59]Wehman JC, Holmes DR, Ecker RD, et al. Intravascularult rasound identification of int-raluminal embolic plaque material during carotid angioplasty with stenting [J].Cathet Cardiovasc Intervent,2006,68:853.
[60]高山,黄家兴.经颅多普勒超声(TCD)的诊断技术与临床应用[M],北京：中国协和大学出版社,2004：1-4.
[61]王卫真,吴凌峰,闵生辉.经颅多普勒、颈动脉彩超和全脑血.管造影术在缺血性脑血管病诊断中的应用[J].南吕大学学报(医学版)2010,50(11).
[62]许云飞,尉传社,王峥超.颈动脉狭窄的MRA与DSA比较研究[J].现代医药卫生2008,24(13).
[63]朱锡旭,陈君坤,卢光明.颈动脉狭窄MRA和彩色多普勒超声对照研究[J].南京大学学报(白然科学),1999,35(5).
[64]戈明媚,刘志饮,刘晓林.磁共振3D TOF MRA技术在颈动脉血管成像中的应用[J].医疗卫生装备,2008,29(10).
[65]许云飞,尉传社,王峥超.颈动脉狭窄的MRA与DSA比较研究[J].现代医药卫生,2008,24(13).
[66]彭颖,唐光健,-王仪生.脑动脉狭窄的影像诊断：CT血管成像与磁共振血管成像的对照性研究[J].中国医学影像技术,1999,15(9).
[67]Randoux B,Marro B,Koskas F,et al.Carotid artery stenosis:pospective comparison of CT,there-dimensional gadolinium-enhanced MR,and conventional angiography. Radidogy,2001,220(1):179-185.
[68]DAWKINS AA, EVANS AL, WATTAM J, et al. Complications of cerebral angiography:a prospective analysis of 2,924 consecutive procedures. [J] Neuroradiology,2007,49:753-759.
[69]Komiyama M,Yamanaka K,Nishikawa M,et al.Prospective analysis of complications of catheter cerebral angiography in the digital subtraction angiography and magnetic resonance era.Neurol Med Chir(Tokyo),1998,38(9):534-539.
[70]Hirai T,Korogi Y,Oon K,et al.Maximum slenosis of extracranial ICA:effect of luminal morphology on stenosis measurement by using CT angiography and conventional DSA.Radiology,2001,221:802-809.
[71]周明利,冯骏,屈天荣.磁共振血管造影与数字藏影血管造影在颅内动脉瘤术后检查中的价值比较[J].西安交通大学学报(医学版),2012.
[72]Henry JM, Barnett JP, Bennett M, et al卒中病理生理,诊断及其治疗[M].高旭光,译.第3版.沈阳：辽宁科学技术出版社,2001：13-15.
[73]Korybalska K, Kawka E, Breborowicz A, et al. Atorvastatin does not impair endothelial cell wound healing in an in vitro model of vascular injury[J]. J Physiol Pharmacol,2012,63(4): 389-395.
[74]刘坤梅,丁小君,刘修燕,阳恩.阿托伐他汀钙对颈动脉粥样硬化患者近期血管内皮的保护作用[J].华西医学2013，28(1)
[75]Kadoglou NP, Sailer N, Moumtzouoglou A. et al. Adipokines:anovel link between adiposity and carotid plaque vulnerability[J]. EurJ Clin Invest,2012,42(12):1278-1286.
[76]Grundy SM, Cleeman JI, Merz CN.et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines[J].Circulation,2004,110(2): 227-239.
[77]华先平,杨勇,陈平英.瑞舒伐他汀联合阿司匹林与单药治疗颈动脉粥样硬化的疗效比较[J].医药导报.2011,30(6).
[78]Oda M N, Bielicki J K, Ho T T, et al.Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins[J].Biochem Biophys Rescommun,2002,290(3):921-927.
[79]Ren S, Shen G X. Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells [J].Aterioscler Thromb Vasc Biol,2000,20: 1688-1693.
[80]Uittenbogaard A, Shaul P W, Yuhanna I S, et al. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae [J].JBiol Chem,2000,275:11278-11283.
[81]刘俊艳,沈宏锐.阿托伐他汀抗动脉粥样硬化的分子机制研究[J].脑与神经疾病杂志.2006，14：99.
[82]Barter PJ, Brandrup-Wognsen G, Palmer MK, Nicholls SJ. Effects of statins on the concentration of high-density lipoprotein cholesterol and its relation to change in low-density lipoprotein cholesterol:results from the VOYAGER database. J Am Coll Cardiol. 2009;53:1021-1087.
[83]杨阳,张海波,蒋立新.升高高密度脂蛋白胆固醇药物的相关研究进展[J].中国分子心脏病学杂志.2010：6.
[84]Bloomfield D, Carlson GL, Sapre A, et al. Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients. Am Heart J 2009; 157:352-60.
[85]陈永福,王绿娅,吕树铮.动脉粥样硬化不稳定斑块的药物治疗进展[J].现代生物医学进展,2008,8(8).
[86]Newby AC.Do metalloproteinases destabilize vulnerable atherosclerotic plaques?[J].Curr Opin Lipidol,2006,17:556-6.
[87]Brown DL,Desai KK,Vakili BA.Nouneh C,et al.Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes(MIDAS) pilot trial[J].Arteriosder Thromb Vase Biol,2004,24:733-8.
[88]高连生,郝树森,陈稚丽.体外超声波治疗颈动脉粥样硬化斑块的临床研究[J].河北医药,2010,32(11).
[89]诬继崔,郑兴.转染VHGI基因骨髓间允质干细胞移植改善心肌梗死肝心脏重构[J].第(?)军医大学博士论文.2005.
[90]刘鹏霞,韩忠朝.间充质干细胞输注在血管内皮细胞损伤和动脉粥样硬化中的作用[J].中国协和医学院研究生院.2009.
[91]张忠田.基因治疗动脉粥样硬化有了新途径(N).健康报,2010(2).
[92]Men BZ,Zhou DB, Shi HY, et al. Apoptotic gene Bax expression in Carotid Plaque [J] Neurosci Bull,2006,22 (1); 58-62.
[93]门保忠,周定标,石怀银.颈动脉粥硬化分子病理研究进展[J].中国动脉硬化杂志,2004,12(3)：370-372.
[94]门保忠,周定标,石怀银.Bax基因在人颈动脉粥样硬化斑块中的表达[J].军医进修学院学报，2010),31(6).
[95]Higashi Y, Sasaki S, Nakagawa K, et al.Hndothelial function and oxidative stress in renovascular hypertension[J].N Engl J Med,2002,223(346):1954-1962.
[96]张勤奕,张茁,展红霞.颈动脉粥样硬化与颈动脉内膜剥脱术[J].中国动脉硬化杂志,2010,18(9).
[97]Brott TG, Hobson RW, George Howard, et al. Stenting versus endarterectomy for treatment of carotid-artery stenos is [J]. NEJM,2010,(363):11-23.
[98]Yadav JS, Wholey MH, Kuntz RE, et al.Stenting and Angiop lasty with Protection in Patients at High Risk for Endarterectomy Investigators Protected carotid-artery stenting versus endarterectomy in high-risk patients N Engl J Med,2004,351:1493-1501.
[99]Alhaddad IA.Carotid artery surgery vsstent:a cardiovascular perspective Catheter Cardiovasc Interv,2004,63:377-384.
[100]廖伟光,欧玉英,梁爱荣.颈动脉粥样硬化高危患者应用纤维膳食干预效果的研究[J].中华临床医师杂志,2011,5(18).
[101]Williams J,Kaplan JR,Suparto IH,et al.Efects of exercise on cardiovascular outcomes in monkeys with risk factors for coronary heart diease.Arerioscler Thromb Vasc Biol,2003,23(5):864-871.
[1]HennericiM, Reifschnneider G, TrockelU, et al.Detection of early atherosclerotic lesions by dup lex scanning of the carotid artery.J Chin Ultrasound,1984,12:455-463.
[2]王薇,赵冬,刘静.中国35-64岁人群心血管病危险因素与发病危险的前瞻性研究.中华心血管病杂志,2003,31：902-908.
[3]李玉林,病理学[M],7版,北京：人民卫生出版社,2008：113.
[4]唐杰,李俊来,徐建宏.彩色多普勒在颈动脉内膜切除术中的应用[J].中国超声医学杂志,2003,19(7)：492-494.
[5]王纯止,徐智章.超声诊断学[M],2版,北京：人民卫生出版社,2010：150.
[6]贺顺龙,朱兆洪,陈宝国,林煜,白建萍,邓国良,梁玉玲.超声检测脑血管病高危人群颈动脉内皮舒张功能[A].中国动脉硬化杂志,2004,12(2).
[7]万杰清,李善泉,江基尧.血管内超声在颈动脉粥样硬化研究中的应用——与血管造影和组织病理学的比较研究.中国卒中杂志,2008,3(12).
[8]Glagov S, Weisenberg E, Zanns CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries[J]. N Engl J Med,1987,316:1371-1375.
[9]洪钰锟,迟路湘,宋治远.血管内超声用于颈动脉狭窄诊治的研究.重庆医学,2008,37(23).
[10]Clark DJ,Lessio S,O' Donoghue M,et al. Safety and utility of int ravascular ult rasound guided carotid artery stenting[J]. Cathet Cardiovasc Intervent,2004,63:355.
[11]Wehman JC, Holmes DR, Ecker RD, et al. Int ravascularult rasound identification of int raluminal embolic plaque material during carotid angioplasty with stenting[J].Cathet Cardiovasc Intervent,2006,68:853.
[12]高山，黄家兴.经颅多普勒超声(TCD)的诊断技术与临床应用,北京：中国协和大学出版社,2004：1-41.
[13]王卫真,吴凌峰,闵生辉.经颅多普勒、颈动脉彩超和全脑血管造影术在缺血性脑血管病诊断中的应用.南昌大学学报(医学版)2010,50(11).
[14]许云飞，尉传社,王峥超.颈动脉狄窄的MRA与DSA比较研究.现代医药卫生2008,24(13).
[15]朱锡旭,陈君坤,卢光明.颈动脉狭带MRA和彩色多普勒超声对照研究.南京大学学报(自然科学),1999,35(5).
[16]戈明媚,刘志饮,刘晓林.磁共振3D TOF MRA技术在颈动脉血管成像中的应用.医疗卫生装备,2008,29(10).
[17]许云飞,尉传社，王峥超.颈动脉狭窄的MRA与DSA比较研究.现代医药卫生,2008,24(13).
[18]彭颖,唐光健,王仪生.脑动脉狄窄的影像诊断：CT血管成像与磁共振血管成像的对照性研究.中国医学影像技术,1999,15(9).
[19]Randoux B,Marro B,Koskas F,et al.Carotid artery stenosis.pospective comparison of CT,there-dimensional gadolinium-enhanced MR,and conventional angiography.Radidogy.2001,220(1):179-185.
[20]DAWKINS AA, HVANS AL, WATT AM J, et al. Complications of cerebral angiography:a prospective analysis of 2,924 consecutive procedures. [J] Neuroradiology,2007,49:753-759.
[21]K.omiyama M.Yamanaka K,Nishikawa M,et al.Prospective analysis of complications of catheter cerebral angiography in the digital subtraction angiography and magnetic resonance era.Neurol Med Chir(Tokyo),1998,38(9):534-539.
[22]Hirai T,Korogi Y,Oon K,et al.Maximum slenosis of extracranial ICA:effect of luminal morphology on stenosis measurement by using CT angiography and conventional DS A. Radiology,2001,221:802-809.
[23]周明利,冯骏,屈天荣.磁共振血.管造影与数字减影血.管造影在颅内动脉瘤术后检查中的价值比较.西安交通大学学报(医学版),2012.
[24]陈永福,王绿娅,吕树铮.动脉粥样硬化不稳定斑块的药物治疗进展.现代生物医学进展,2008,8(8).
[25]Newby AC.Do metalloproteinases destabilize vulnerable atherosclerotic plaques?[J].Curr Opin Lipidol,2006,17:556-6.
[26]Brown DL,Desai KK,Vakili BA,Nouneh C,et al.Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes(MIDAS) pilot trial[J].Arteriosder Thromb Vase Biol,2004,24:733-8.
[27]高连生,郝树森,陈稚丽.体外超声波治疗颈动脉粥样硬化斑块的临床研究.河北医药,2010,32(11).
[28]崔继福,郑兴.转染VEGF基因骨髓间充质于细胞移植改善心肌梗死后心脏重构.第二军医人学博士论文.2005.
[29]刘鹏霞，韩忠朝.间充质干细胞输注在血管内皮细胞损伤和动脉粥样硬化中的作用.中国协和医学院研究生院.2009.
[30]张忠田.基因治疗动脉粥样硬化有了新途径(N).健康报,2010(2).
[31]Men BZ. Zhou DB, Shi HY. et al. Apoptotic gene Bax expression in Carotid Plaque [J]. Neurosci Bull,2006,22 (1):58-62.
[32]门保忠,周定标,石怀银.颈动脉粥样硬化分子病理学研究进展[J].中国动脉硬化杂志,2004，12(3)：370-372.
[33]门保忠,周定标,石怀银.Bax基因在人颈动脉粥样硬化斑块中的表达.军医进修学院学报,2()l(),31(6).
[34]Higashi Y, Sasaki S, Nakagawa K, et al.Endothelial function and oxidative stress in renovascular hypertension[J].N Engl J Med,2002,223(346):1954-1962.
[35]张勤奕,张茁,展红夏.颈动脉粥样硬化与颈动脉内膜剥脱术.中国动脉硬化杂志,2010,18(9).
[36]Brott TG, Hobson RW, George Howard, et al. Stenting versus endarterectomy for treatment of carotid-artery stenos is [J]. NEJM,2010,(363):11-23.
[37]Yadav JS, Wholey MH, Kuntz RE. et al.Stenting and Angiop lasty with Protection in Patients at High Risk for Endarterectomy Investigators Protected carotid-artery stenting versus endarterectomy in high-risk patients N Engl J Med,2004.351:1493-1501.
[38]Alhaddad IA.Carotid artery surgery vsstent:a cardiovascular perspective Catheter Cardiovasc Interv.2004.63:377-384.
[2]白雁明,胡淑丽,秦艳芬,朱晓波.颈动脉狭窄与复发性脑梗死的关系探讨[J].当代医学,2011,17(19).
[3]王拥军.应加强颈动脉粥样硬化的基础和临床研究[J].中华神经科杂志,2001,34(5)：257-258.
[4]赵红梅,辛涛.高同型半胱氨酸血症与心脑血管病[J].陕西医学杂志,2006,11(35)1491-1492.
[5]马雪兴,刘玉明,吾柏铭.蛋氨酸对兔同型半胱氨酸水平及动脉粥样硬化的影响[J].中国心血管杂志,2002,7(4)：231-234.
[6]WerstuckG.H,LentzS.R,DayalS,et al.Homocysteine-induced endoplasmic reticulum Stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways.Journal of clinical investigation,2001,107(10):1263-1273.
[7]Zhou J,Werstuck G.H,Lhotak S,et al.Association of Multiple Cellular Stress Pathways With Accelerated Atherosclerosis In Hyperhomocysteinemic A polipo protein E-Deficient Mice.Circulation,2004,110(2):207-213.
[8]Kannellis J, Kang DH.Uric acid as a mediator of endothelial dysfunction, inflammation and vascular d isease [J]Sem in Nephro,12005(25):39-42.
[9]王杏儒,赵娜萍,刘瑛.血浆纤维蛋白原浓度对颈动脉粥样硬化程度的影响[J].河北医药,2007，29：712.
[10]Megson E,Fitzsimmons T,Dharmapatni K,et al.C-reactive protein in gingival crevicular fluid may be indicative of systemic inflammation[J].Clin Periodontol,2010,37(9):797-804.
[11]Ylostalo P,Anttila S,Rajala U,et al.Periodontal infection and subclinical atherosclerosis:the role of high-density lipoprotein as a modifying factor[J].Clin Periodontol,2010,37(7):617-624.
[12]D' Aiuto F.Parker M,Nibali L,Suvan J,Lessem J,Tonetti MS,Periodontal infections cause changes in traditional and novel cardiovascular risk factors:results from a randomized controlled clinical trial[J].Am Heart,2006,151(5):977-984.
[13]王瑾,刘海夏,陈红.牙周疾病与颈动脉狭窄程度的关系[J].中国老年学杂志,2012,32.
114] LI GW.zheng GY,LI JG.et al. Relationship between carotid atherosclerosis and cerebral infarction[J].Chin Med Sci,2010.25(1):32-37.
[15]王兰琴,魏秀娥,荣良群.脑梗死患者颈动脉斑块稳定性及其相关因素分析[J].中国实用神经疾病杂志,2012,15(4).
[16]Ross R.Atherosclerosis-Aninflammatory disease[J].N Engl J Med,1999,340:115-126.
[17]赵东娅.颈动脉粥样硬化与脑梗死复发的关系研究[J].中国医药指南,2011,9(22)
[18]姚光辉,余新,朱红梅.颈动脉粥样硬化与血清同型半胱氨酸水平变化的关系[J].中国自然医学杂志.2008,10(6).
[19]赵红梅,辛涛.高同型半胱氨酸血症与心脑血管病[J].陕西医学杂志,2006，35：1492-1492.
[20]Kawamoto.Takaaki Doi and Hitoo Tokunaga.Association of Plasma Homocysteine Concentrations with. ORIGINAL ARTICLE,2011,12 (40)
[21]耿彬,常林,杜军保.防治高同型半胱氨酸血症的新策略[J].北京大学学报(医学版)2005,37(32).
[22]谢秋玲.颈动脉彩超筛查3000例临床分析及脑卒中管理系统的健康干预研究[J].中国社区医师,2011,29(13).
[23]Casella IB,Sotelo FJB,Yamazaki Y,et al.Comparison of common carotid artery intima-media thickness between brazilian eurodescendants and afrodescendants with atherosclerosis risk factors[J].Clinics,2009,64(7):657-64.
[24]Alon Eisen, MD; Michal Benderly, PhD; Uri Goldbourt, PhD; Moti Haim, MD.Association of elevated serum uric acid with coronary heart disease in diabetes mellitus. Clin Cardiol,2013 Feb;36(2):110-6.
[25]Kang DH,Park SK, Lee IK.et al. Uric acid-induced C-reactive protein expression:implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol,2005; 16:3553-3562.
[26]Hayden MR, Tyagi SC. Uric acid:a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus:the urate redox shuttle. Nutrition Metabolism,2004; 1:1-15.
[27]Watanabe S, Kang DH, Feng L, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity[J].Hypertension,2002,40(3):355-360.
[28]Tribouilloy C, Pelt ier M, Colas L, et al. Fibrinogen is an independent marker for thoraci caortic atherosclerosis [J]. Am J Cardiol,1998,81(3):321-326.
[29]Naito M, Hayashi T, Lguchi A. New approaches to the prevention of atherosclerosis[J].Drugs,1995,50 (3):440-453.
[30]解龙吕,黄如训.纤维蛋白原与脑动脉系统血栓形成[J].国外医学脑血管病分册,2002,l()(5)：370-376.
[31]Bini A, Kudryk BJ. Fibrinogen and fibrin in the arterial wall [J].Thromb Res,1994,75(3): 337-341.
[32]O' Connor S, Taylor C, Campbell LA. et al. Potential infectious etiologies of atherosclerosis:A multifactorial perspective[J]. Emerg Infect Dis,2001.7(5):780-788.
[33]D' Aiuto F, Parkar M. Andreou G. et al. Periodontitis and atherogenesis:Causal association or simple coincidence[J]. J Clin Periodontol,2004,31 (5):402-411.
[34]Gibson FC 3rd, Hong C.Chou HH, et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice[J]. Circulation.2004.109 (22) 2801-2806.
[35]Katz.IT, Shannon RP. Bacteria and coronary atheroma:More fingerprints but no smoking gun[J]. Circulation,2006,113 (7):920-922.
[36]Randomised trial of cholesterol lowering in 4444patients with coronary heart disease:the Scandinavian Simvastatin Survival Study(4S)[J].Lancet,1994,344:1383-1389.
[37]Prevention of cardiovascular events and death with pravastatin In patients with coronary heart disease and a broad range of initial cholesterol levels.The Long-Term intervention with Pravastatin in ischaemic Disease(LIPID)Study Group[J].NEngl J Med.1998.339:1349-1357.
[38]PhanB A,Chu B,Pollssar N,I latsukami T S,Yuan C,Zhao X Q. Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging.[J]Int J Cardiovasc Imaging,2007,23:337-342.
[39]朱云松,王玲,李进.血管平滑肌细胞凋亡与动脉粥样硬化[J].国外医学老年医学分册,1997,18(2)：53-57.
[40]Lane P. Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in Thelper (Th) 1 and Th2 cells [J].J Exp Med,2000,191 (2):201-206.
[41]Wang X, Ria M, Kelmenson PM, et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility [J]. Nat Genet,2005,37 (4) 365-372.
[42]中华神经科学会.各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6)：319-21.
[43]吴晓晖,于小红,盛红专.血压变异性与高血压伴颈动脉粥样硬化的关系[J].中国交通医学杂志,2005,19(6).
[44]Matsmoto K,Sera Y,Nakamura H,et al.Correlation between common carotid arterial wall thickness and ischemic stroke in patients with type 2 diabetes mellitus[J].Metabolism,2002,51:2421-7.
[45]赵婷,朱秀英,陈琳.再发脑梗死危险因素分析及预防[J].新疆医科大学学报,2001,24(2)：167-8.
[46]Smimov AV,Potrish chev NN,Panina llu Glomerular filtration rate is an indicator of endothelial function at carly stages of chronic kidney disense[J].Tar Arkh,2007,79:25-30.
[47]杨倩,于德林.年龄与性别对颈动脉粥样硬化影响的超声观察[J].临床超声医学杂志.2012年8月第14卷第8期.
[48]Bode-Boger SM, Scalera F, Martens-Lobenhoffer J, et al. Asymetric dimethylarginine (ADMA) accelerates cell senescence. Vasc Med,2005,10 (Suppl 1):65-71.
[49]Cevik D, Unay O, Durmusoglu F, et al. Plasma markers of No synthase activity in women after ovarian hyperstimulation:influence of estradiol on ADMA. Vasc Med.2006,11 (1):7-12.
[50]SINNING C, WILD PS, ECHEVARRIA F M, et al. Sex differences in early carotid atherosclerosis (from the Community-Based Gutenberg-Heart Study) [J].Am J Cardiol,2011,107(12):1841-1847.
[51]尚娟.激素替代疗法与冠心病预防[J].中华医学实践杂志,2006,7(12)：1429-1432.
[52]袁志敏.早期颈动脉粥样硬化的性别差异[J].心血管病学进展.2012年7月第33卷第4期.
[53]王纯正,徐智章.超声诊断学[M],2版,北京：人民卫生出版社,2010：150.
[54]贺顺龙,朱兆洪,陈宝国,林煜,白建萍,邓国良,梁玉玲.超声检测脑血管病高危人群颈动脉内皮舒张功能[A].中国动脉硬化杂志,2004,12(2).
[55]万杰清,李善泉,江基尧.血管内超声在颈动脉粥硬化研究中的应用——与血管造影和组织病理学的比较研究[J].中国卒中杂志,2008,3(12).
[56]Glagov S, Weisenberg E, Zanns CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries[JJ. N Engl J Med,1987,316:1371-1375.
[57]洪钰锟,迟路湘，宋治运.血管内超声用于颈动脉狭窄诊治的研究[J].重庆医学，2008,37(23).
[58]Clark DJ.Lessio S.O' Donoghue M,et al. Safety and utility of int ravascular ult rasound guided carotid artery stenting[J]. Cathet Cardiovasc Intervent,2004,63:355.
[59]Wehman JC, Holmes DR, Ecker RD, et al. Intravascularult rasound identification of int-raluminal embolic plaque material during carotid angioplasty with stenting [J].Cathet Cardiovasc Intervent,2006,68:853.
[60]高山,黄家兴.经颅多普勒超声(TCD)的诊断技术与临床应用[M],北京：中国协和大学出版社,2004：1-4.
[61]王卫真,吴凌峰,闵生辉.经颅多普勒、颈动脉彩超和全脑血.管造影术在缺血性脑血管病诊断中的应用[J].南吕大学学报(医学版)2010,50(11).
[62]许云飞,尉传社,王峥超.颈动脉狭窄的MRA与DSA比较研究[J].现代医药卫生2008,24(13).
[63]朱锡旭,陈君坤,卢光明.颈动脉狭窄MRA和彩色多普勒超声对照研究[J].南京大学学报(白然科学),1999,35(5).
[64]戈明媚,刘志饮,刘晓林.磁共振3D TOF MRA技术在颈动脉血管成像中的应用[J].医疗卫生装备,2008,29(10).
[65]许云飞,尉传社,王峥超.颈动脉狭窄的MRA与DSA比较研究[J].现代医药卫生,2008,24(13).
[66]彭颖,唐光健,-王仪生.脑动脉狭窄的影像诊断：CT血管成像与磁共振血管成像的对照性研究[J].中国医学影像技术,1999,15(9).
[67]Randoux B,Marro B,Koskas F,et al.Carotid artery stenosis:pospective comparison of CT,there-dimensional gadolinium-enhanced MR,and conventional angiography. Radidogy,2001,220(1):179-185.
[68]DAWKINS AA, EVANS AL, WATTAM J, et al. Complications of cerebral angiography:a prospective analysis of 2,924 consecutive procedures. [J] Neuroradiology,2007,49:753-759.
[69]Komiyama M,Yamanaka K,Nishikawa M,et al.Prospective analysis of complications of catheter cerebral angiography in the digital subtraction angiography and magnetic resonance era.Neurol Med Chir(Tokyo),1998,38(9):534-539.
[70]Hirai T,Korogi Y,Oon K,et al.Maximum slenosis of extracranial ICA:effect of luminal morphology on stenosis measurement by using CT angiography and conventional DSA.Radiology,2001,221:802-809.
[71]周明利,冯骏,屈天荣.磁共振血管造影与数字藏影血管造影在颅内动脉瘤术后检查中的价值比较[J].西安交通大学学报(医学版),2012.
[72]Henry JM, Barnett JP, Bennett M, et al卒中病理生理,诊断及其治疗[M].高旭光,译.第3版.沈阳：辽宁科学技术出版社,2001：13-15.
[73]Korybalska K, Kawka E, Breborowicz A, et al. Atorvastatin does not impair endothelial cell wound healing in an in vitro model of vascular injury[J]. J Physiol Pharmacol,2012,63(4): 389-395.
[74]刘坤梅,丁小君,刘修燕,阳恩.阿托伐他汀钙对颈动脉粥样硬化患者近期血管内皮的保护作用[J].华西医学2013，28(1)
[75]Kadoglou NP, Sailer N, Moumtzouoglou A. et al. Adipokines:anovel link between adiposity and carotid plaque vulnerability[J]. EurJ Clin Invest,2012,42(12):1278-1286.
[76]Grundy SM, Cleeman JI, Merz CN.et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines[J].Circulation,2004,110(2): 227-239.
[77]华先平,杨勇,陈平英.瑞舒伐他汀联合阿司匹林与单药治疗颈动脉粥样硬化的疗效比较[J].医药导报.2011,30(6).
[78]Oda M N, Bielicki J K, Ho T T, et al.Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins[J].Biochem Biophys Rescommun,2002,290(3):921-927.
[79]Ren S, Shen G X. Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells [J].Aterioscler Thromb Vasc Biol,2000,20: 1688-1693.
[80]Uittenbogaard A, Shaul P W, Yuhanna I S, et al. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae [J].JBiol Chem,2000,275:11278-11283.
[81]刘俊艳,沈宏锐.阿托伐他汀抗动脉粥样硬化的分子机制研究[J].脑与神经疾病杂志.2006，14：99.
[82]Barter PJ, Brandrup-Wognsen G, Palmer MK, Nicholls SJ. Effects of statins on the concentration of high-density lipoprotein cholesterol and its relation to change in low-density lipoprotein cholesterol:results from the VOYAGER database. J Am Coll Cardiol. 2009;53:1021-1087.
[83]杨阳,张海波,蒋立新.升高高密度脂蛋白胆固醇药物的相关研究进展[J].中国分子心脏病学杂志.2010：6.
[84]Bloomfield D, Carlson GL, Sapre A, et al. Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients. Am Heart J 2009; 157:352-60.
[85]陈永福,王绿娅,吕树铮.动脉粥样硬化不稳定斑块的药物治疗进展[J].现代生物医学进展,2008,8(8).
[86]Newby AC.Do metalloproteinases destabilize vulnerable atherosclerotic plaques?[J].Curr Opin Lipidol,2006,17:556-6.
[87]Brown DL,Desai KK,Vakili BA.Nouneh C,et al.Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes(MIDAS) pilot trial[J].Arteriosder Thromb Vase Biol,2004,24:733-8.
[88]高连生,郝树森,陈稚丽.体外超声波治疗颈动脉粥样硬化斑块的临床研究[J].河北医药,2010,32(11).
[89]诬继崔,郑兴.转染VHGI基因骨髓间允质干细胞移植改善心肌梗死肝心脏重构[J].第(?)军医大学博士论文.2005.
[90]刘鹏霞,韩忠朝.间充质干细胞输注在血管内皮细胞损伤和动脉粥样硬化中的作用[J].中国协和医学院研究生院.2009.
[91]张忠田.基因治疗动脉粥样硬化有了新途径(N).健康报,2010(2).
[92]Men BZ,Zhou DB, Shi HY, et al. Apoptotic gene Bax expression in Carotid Plaque [J] Neurosci Bull,2006,22 (1); 58-62.
[93]门保忠,周定标,石怀银.颈动脉粥硬化分子病理研究进展[J].中国动脉硬化杂志,2004,12(3)：370-372.
[94]门保忠,周定标,石怀银.Bax基因在人颈动脉粥样硬化斑块中的表达[J].军医进修学院学报，2010),31(6).
[95]Higashi Y, Sasaki S, Nakagawa K, et al.Hndothelial function and oxidative stress in renovascular hypertension[J].N Engl J Med,2002,223(346):1954-1962.
[96]张勤奕,张茁,展红霞.颈动脉粥样硬化与颈动脉内膜剥脱术[J].中国动脉硬化杂志,2010,18(9).
[97]Brott TG, Hobson RW, George Howard, et al. Stenting versus endarterectomy for treatment of carotid-artery stenos is [J]. NEJM,2010,(363):11-23.
[98]Yadav JS, Wholey MH, Kuntz RE, et al.Stenting and Angiop lasty with Protection in Patients at High Risk for Endarterectomy Investigators Protected carotid-artery stenting versus endarterectomy in high-risk patients N Engl J Med,2004,351:1493-1501.
[99]Alhaddad IA.Carotid artery surgery vsstent:a cardiovascular perspective Catheter Cardiovasc Interv,2004,63:377-384.
[100]廖伟光,欧玉英,梁爱荣.颈动脉粥样硬化高危患者应用纤维膳食干预效果的研究[J].中华临床医师杂志,2011,5(18).
[101]Williams J,Kaplan JR,Suparto IH,et al.Efects of exercise on cardiovascular outcomes in monkeys with risk factors for coronary heart diease.Arerioscler Thromb Vasc Biol,2003,23(5):864-871.
[1]HennericiM, Reifschnneider G, TrockelU, et al.Detection of early atherosclerotic lesions by dup lex scanning of the carotid artery.J Chin Ultrasound,1984,12:455-463.
[2]王薇,赵冬,刘静.中国35-64岁人群心血管病危险因素与发病危险的前瞻性研究.中华心血管病杂志,2003,31：902-908.
[3]李玉林,病理学[M],7版,北京：人民卫生出版社,2008：113.
[4]唐杰,李俊来,徐建宏.彩色多普勒在颈动脉内膜切除术中的应用[J].中国超声医学杂志,2003,19(7)：492-494.
[5]王纯止,徐智章.超声诊断学[M],2版,北京：人民卫生出版社,2010：150.
[6]贺顺龙,朱兆洪,陈宝国,林煜,白建萍,邓国良,梁玉玲.超声检测脑血管病高危人群颈动脉内皮舒张功能[A].中国动脉硬化杂志,2004,12(2).
[7]万杰清,李善泉,江基尧.血管内超声在颈动脉粥样硬化研究中的应用——与血管造影和组织病理学的比较研究.中国卒中杂志,2008,3(12).
[8]Glagov S, Weisenberg E, Zanns CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries[J]. N Engl J Med,1987,316:1371-1375.
[9]洪钰锟,迟路湘,宋治远.血管内超声用于颈动脉狭窄诊治的研究.重庆医学,2008,37(23).
[10]Clark DJ,Lessio S,O' Donoghue M,et al. Safety and utility of int ravascular ult rasound guided carotid artery stenting[J]. Cathet Cardiovasc Intervent,2004,63:355.
[11]Wehman JC, Holmes DR, Ecker RD, et al. Int ravascularult rasound identification of int raluminal embolic plaque material during carotid angioplasty with stenting[J].Cathet Cardiovasc Intervent,2006,68:853.
[12]高山，黄家兴.经颅多普勒超声(TCD)的诊断技术与临床应用,北京：中国协和大学出版社,2004：1-41.
[13]王卫真,吴凌峰,闵生辉.经颅多普勒、颈动脉彩超和全脑血管造影术在缺血性脑血管病诊断中的应用.南昌大学学报(医学版)2010,50(11).
[14]许云飞，尉传社,王峥超.颈动脉狄窄的MRA与DSA比较研究.现代医药卫生2008,24(13).
[15]朱锡旭,陈君坤,卢光明.颈动脉狭带MRA和彩色多普勒超声对照研究.南京大学学报(自然科学),1999,35(5).
[16]戈明媚,刘志饮,刘晓林.磁共振3D TOF MRA技术在颈动脉血管成像中的应用.医疗卫生装备,2008,29(10).
[17]许云飞,尉传社，王峥超.颈动脉狭窄的MRA与DSA比较研究.现代医药卫生,2008,24(13).
[18]彭颖,唐光健,王仪生.脑动脉狄窄的影像诊断：CT血管成像与磁共振血管成像的对照性研究.中国医学影像技术,1999,15(9).
[19]Randoux B,Marro B,Koskas F,et al.Carotid artery stenosis.pospective comparison of CT,there-dimensional gadolinium-enhanced MR,and conventional angiography.Radidogy.2001,220(1):179-185.
[20]DAWKINS AA, HVANS AL, WATT AM J, et al. Complications of cerebral angiography:a prospective analysis of 2,924 consecutive procedures. [J] Neuroradiology,2007,49:753-759.
[21]K.omiyama M.Yamanaka K,Nishikawa M,et al.Prospective analysis of complications of catheter cerebral angiography in the digital subtraction angiography and magnetic resonance era.Neurol Med Chir(Tokyo),1998,38(9):534-539.
[22]Hirai T,Korogi Y,Oon K,et al.Maximum slenosis of extracranial ICA:effect of luminal morphology on stenosis measurement by using CT angiography and conventional DS A. Radiology,2001,221:802-809.
[23]周明利,冯骏,屈天荣.磁共振血.管造影与数字减影血.管造影在颅内动脉瘤术后检查中的价值比较.西安交通大学学报(医学版),2012.
[24]陈永福,王绿娅,吕树铮.动脉粥样硬化不稳定斑块的药物治疗进展.现代生物医学进展,2008,8(8).
[25]Newby AC.Do metalloproteinases destabilize vulnerable atherosclerotic plaques?[J].Curr Opin Lipidol,2006,17:556-6.
[26]Brown DL,Desai KK,Vakili BA,Nouneh C,et al.Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes(MIDAS) pilot trial[J].Arteriosder Thromb Vase Biol,2004,24:733-8.
[27]高连生,郝树森,陈稚丽.体外超声波治疗颈动脉粥样硬化斑块的临床研究.河北医药,2010,32(11).
[28]崔继福,郑兴.转染VEGF基因骨髓间充质于细胞移植改善心肌梗死后心脏重构.第二军医人学博士论文.2005.
[29]刘鹏霞，韩忠朝.间充质干细胞输注在血管内皮细胞损伤和动脉粥样硬化中的作用.中国协和医学院研究生院.2009.
[30]张忠田.基因治疗动脉粥样硬化有了新途径(N).健康报,2010(2).
[31]Men BZ. Zhou DB, Shi HY. et al. Apoptotic gene Bax expression in Carotid Plaque [J]. Neurosci Bull,2006,22 (1):58-62.
[32]门保忠,周定标,石怀银.颈动脉粥样硬化分子病理学研究进展[J].中国动脉硬化杂志,2004，12(3)：370-372.
[33]门保忠,周定标,石怀银.Bax基因在人颈动脉粥样硬化斑块中的表达.军医进修学院学报,2()l(),31(6).
[34]Higashi Y, Sasaki S, Nakagawa K, et al.Endothelial function and oxidative stress in renovascular hypertension[J].N Engl J Med,2002,223(346):1954-1962.
[35]张勤奕,张茁,展红夏.颈动脉粥样硬化与颈动脉内膜剥脱术.中国动脉硬化杂志,2010,18(9).
[36]Brott TG, Hobson RW, George Howard, et al. Stenting versus endarterectomy for treatment of carotid-artery stenos is [J]. NEJM,2010,(363):11-23.
[37]Yadav JS, Wholey MH, Kuntz RE. et al.Stenting and Angiop lasty with Protection in Patients at High Risk for Endarterectomy Investigators Protected carotid-artery stenting versus endarterectomy in high-risk patients N Engl J Med,2004.351:1493-1501.
[38]Alhaddad IA.Carotid artery surgery vsstent:a cardiovascular perspective Catheter Cardiovasc Interv.2004.63:377-384.